Stock JANX JANUX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Janux Therapeutics, Inc.

Equities

JANX

US47103J1051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
53.5 USD +6.13% Intraday chart for Janux Therapeutics, Inc. +17.92% +398.60%
May. 30 Scotiabank Starts Janux Therapeutics With Sector Perform Rating MT
May. 30 Certain Pre Funded Warrants of Janux Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024. CI

Evolution of the average Target Price on Janux Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

4b7fd05aa86cc4d8f.8IX_n4H4eoSEhAfFiqL-aA9eh1rZlcBfLN8iIMwJbVM.hP-srduWKNTsxVH2wZS_BVc4zCzg1_FvQYpJTYQkIDrG97b2x8lX1rzbSg~a59b30d4728e10b4f50fe273e66d8e4f

Analyst Recommendations on Janux Therapeutics, Inc.

Scotiabank Starts Janux Therapeutics With Sector Perform Rating MT
Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating MT
JonesTrading Starts Janux Therapeutics With Buy Rating, $70 Price Target MT
BTIG Starts Janux Therapeutics With Buy Rating, $62 Price Target MT
Cantor Fitzgerald Starts Janux Therapeutics With Overweight Rating, $100 Price Target MT
H.C. Wainwright Adjusts Price Target on Janux Therapeutics to $50 From $35, Keeps Buy Rating MT
Wedbush Adjusts Janux Therapeutics' Price Target to $53 From $24; Keeps Outperform Rating MT
Health Care Up on Rate-Sensitive Sector Bias -- Health Care Roundup DJ
Wedbush Starts Janux Therapeutics at Outperform With $24 Price Target, See 'Attractive' Entry Point Ahead of Initial Clinical Data in H2 MT
William Blair Initiates Coverage for Janux Therapeutics With Outperform Rating MT
JANUX THERAPEUTICS : Evercore ISI Starts Janux Therapeutics at Outperform With $35 Price Target MT
JANUX THERAPEUTICS : BofA Securities Starts Janux Therapeutics at Buy With $35 Price Target MT
JANUX THERAPEUTICS : Cowen Initiates Coverage on Janux Therapeutics With Outperform Rating MT
JANUX THERAPEUTICS : HC Wainwright Starts Janux Therapeutics at Buy With $35 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
53.5 USD
Average target price
61.5 USD
Spread / Average Target
+14.95%
High Price Target
100 USD
Spread / Highest target
+86.92%
Low Price Target
25 USD
Spread / Lowest Target
-53.27%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Janux Therapeutics, Inc.

Scotiabank
Wedbush
JonesTrading Institutional Services
BTIG
Cantor Fitzgerald
HC Wainwright
William Blair & Co.
Cowen
Evercore ISI
BofA Securities

Ratings for Janux Therapeutics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. JANX Stock
  4. Consensus Janux Therapeutics, Inc.